Targeting Myocardial Reperfusion Injury--The Search Continues

N Engl J Med. 2015 Sep 10;373(11):1073-5. doi: 10.1056/NEJMe1509718. Epub 2015 Aug 30.

Authors

Derek J Hausenloy¹, Derek M Yellon

Affiliation

¹ From the Hatter Cardiovascular Institute, University College London, and the National Institute of Health Research University College London Hospitals Biomedical Research Centre - both in London (D.J.H., D.M.Y.); and the Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, and the National Heart Research Institute Singapore, National Heart Center Singapore - both in Singapore, Singapore (D.J.H.).

PMID: 26321104
DOI: 10.1056/NEJMe1509718

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cyclophilins / antagonists & inhibitors*
Cyclosporine / administration & dosage*
Enzyme Inhibitors / administration & dosage*
Female
Humans
Male
Myocardial Infarction / drug therapy*
Percutaneous Coronary Intervention*
Ventricular Remodeling / drug effects*

Substances

Enzyme Inhibitors
Cyclosporine
Cyclophilins

Grants and funding

RG/08/015/26411/BHF_/British Heart Foundation/United Kingdom